Illumina, Inc. (ILMN)
NASDAQ
Closed
Aug 21, 2026
Day's Range
208.5052 wk Range
88.00Overview - ILMN - Illumina, Inc.
Key Statistics
Valuation
Enterprise Value
34.48B
P/E (Trailing)
‪41.00‬
P/E (Forward)
‪35.98‬
PEG Ratio
‪-5.09‬
Price / Sales (TTM)
‪7.37‬
Price / Book
‪11.67‬
EV / EBITDA
‪29.86‬
Profitability
Profit Margin
‪18.33%‬
Operating Margin
‪21.13%‬
Return on Assets
‪8.66%‬
Return on Equity
‪32.33%‬
Ownership
Shares Outstanding
151.00M
Float
148.47M
Short % of Shares Outstanding
‪8.72%‬
Held by Insiders
‪0.19%‬
Held by Institutions
‪105.90%‬
Price stats
Beta
‪1.46‬
50-Day Avg
‪187.54‬
200-Day Avg
‪146.97‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
20 analysts
Average price target
‪$ 198.89‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ILMN - Illumina, Inc.
Peers - ILMN - Illumina, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- ILMNNASDAQIllumina, Inc.33.12BMarket Cap+54.58%52-week change41.05P/E (Trailing)‪18.33%‬Profit Margin
- NTRANASDAQNATERA INC (Common Stock) – ticker 45E47.86BMarket Cap+51.07%52-week change-218.44P/E (Trailing)‪-7.10%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.43.87BMarket Cap-15.16%52-week change39.53P/E (Trailing)‪25.03%‬Profit Margin
- GHNASDAQGuardant Health Inc.22.90BMarket Cap+63.75%52-week change-51.42P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings Inc.17.32BMarket Cap+24.80%52-week change35.96P/E (Trailing)‪17.66%‬Profit Margin
- ICICLRNASDAQICON plc13.28BMarket Cap+0.28%52-week change272.41P/E (Trailing)‪0.32%‬Profit Margin
- RDNTNASDAQRadNet Inc.6.04BMarket Cap+9.41%52-week change1425.75P/E (Trailing)‪-0.93%‬Profit Margin
Profile Summary - ILMN - Illumina, Inc.
About
Illumina, Inc. is a life sciences and diagnostics company that develops, manufactures, and markets tools and integrated systems for the analysis of genetic material. Its primary focus is on next-generation sequencing technologies, providing high-throughput and lower-throughput sequencing instruments, consumables, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
